首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Adrenomedullin suppresses tumour necrosis factor alpha-induced CXC chemokine ligand 10 production by human gingival fibroblasts
【2h】

Adrenomedullin suppresses tumour necrosis factor alpha-induced CXC chemokine ligand 10 production by human gingival fibroblasts

机译:肾上腺髓质素抑制人牙龈成纤维细胞产生的肿瘤坏死因子α诱导的CXC趋化因子配体10

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Periodontal disease is an inflammatory disorder characterized by the involvement of chemokines that are important for the recruitment of leucocytes. Several cytokines, including tumour necrosis factor alpha (TNF-α), are involved in regulating levels of chemokines in periodontal disease. CXC chemokine ligand 10 (CXCL10) is a chemokine related to the migration of T helper 1 cells. In this study, we examined CXCL10 expression in human gingival fibroblasts (HGFs). Moreover, we investigated the effects of adrenomedullin (AM), which is a multi-functional regulatory peptide, on the production of CXCL10 by HGFs. We revealed that TNF-α stimulation induced CXCL10 production by HGFs. HGFs expressed AM and AM receptors, calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP) 2, mRNAs constitutively. AM treatment supressed CXCL10 production by TNF-α-stimulated HGFs. Moreover, we elucidated that AM produced by HGFs inhibited CXCL10 production by HGFs, because AM antagonist enhanced CXCL10 production by HGFs. TNF-α treatment enhanced CRLR and RAMP2 mRNA expression in HGFs. Furthermore, AM is expressed in human periodontal tissues, including both inflamed and clinically healthy tissues. These results suggest that the CXCL10 produced by HGFs may be involved in the migration of leucocytes into inflamed tissues and related to exacerbation of periodontal disease. AM might be a therapeutic target of periodontal disease, because AM can inhibit CXCL10 production by HGFs.
机译:牙周疾病是一种炎症性疾病,其特征在于趋化因子的参与对白细胞的募集很重要。几种细胞因子,包括肿瘤坏死因子α(TNF-α),都参与调节牙周疾病中趋化因子的水平。 CXC趋化因子配体10(CXCL10)是与T辅助1细胞迁移有关的趋化因子。在这项研究中,我们检查了人类牙龈成纤维细胞(HGF)中的CXCL10表达。此外,我们调查了肾上腺髓质素(AM),这是一种多功能的调节肽,对HGF产生CXCL10的影响。我们发现TNF-α刺激诱导HGF产生CXCL10。 HGF组成型表达AM和AM受体,降钙素受体样受体(CRLR)和受体活性修饰蛋白(RAMP)2。 AM治疗抑制了TNF-α刺激的HGF产生CXCL10。此外,我们阐明了HGF产生的AM抑制了HGF产生的CXCL10,因为AM拮抗剂增强了HGF产生的CXCL10。 TNF-α处理可增强HGF中CRLR和RAMP2 mRNA的表达。此外,AM在人牙周组织中表达,包括发炎的和临床上健康的组织。这些结果表明,由HGF产生的CXCL10可能参与白细胞向发炎组织的迁移,并与牙周疾病的恶化有关。 AM可能是牙周疾病的治疗靶标,因为AM可以抑制HGF产生CXCL10。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号